# CXApp Inc.: overview CXAI · Nasdaq · CIK 1820875 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cxai.md) · [Financials](/companies/cxai/financials.md) · [Filings](/companies/cxai/filings.md) · [Insiders](/companies/cxai/insiders.md) Latest reported revenue: [$1.7m](/filings/0001829126-26-008907.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001829126-26-008907). ## Last eight quarters | Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,897](/filings/0001829126-25-009077.md) | [1,661 d](/filings/0001829126-26-002840.md) | [1,224](/filings/0001829126-26-005103.md) | [1,223](/filings/0001829126-26-008907.md) | [1,114](/filings/0001829126-25-009077.md) | [1,022 d](/filings/0001829126-26-002840.md) | [950](/filings/0001829126-26-005103.md) | [1,694](/filings/0001829126-26-008907.md) | | Gross margin | % | [80.4%](/filings/0001829126-26-002840.md) | [86.0% d](/filings/0001829126-26-002840.md) | [87.7%](/filings/0001829126-26-005103.md) | [86.0%](/filings/0001829126-26-008907.md) | [89.0%](/filings/0001829126-26-002840.md) | [86.9% d](/filings/0001829126-26-002840.md) | [83.2%](/filings/0001829126-26-005103.md) | [63.2%](/filings/0001829126-26-008907.md) | | Operating margin | % | [(194.3%)](/filings/0001829126-25-009077.md) | [(169.7%) d](/filings/0001829126-26-002840.md) | [(306.0%)](/filings/0001829126-26-005103.md) | [(336.1%)](/filings/0001829126-26-008907.md) | [(343.4%)](/filings/0001829126-25-009077.md) | [(576.9%) d](/filings/0001829126-26-002840.md) | [(434.1%)](/filings/0001829126-26-005103.md) | [(243.2%)](/filings/0001829126-26-008907.md) | | Net margin | % | [(286.5%)](/filings/0001829126-25-009077.md) | [(239.5%) d](/filings/0001829126-26-002840.md) | [(132.0%)](/filings/0001829126-26-005103.md) | [(256.7%)](/filings/0001829126-26-008907.md) | [(283.4%)](/filings/0001829126-25-009077.md) | [(544.1%) d](/filings/0001829126-26-002840.md) | [(421.4%)](/filings/0001829126-26-005103.md) | [(508.9%)](/filings/0001829126-26-008907.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $k | [(2,073) d](/filings/0001829126-25-009077.md) | [(2,696) d](/filings/0001829126-26-002840.md) | [(984)](/filings/0001829126-26-005103.md) | [(3,023) d](/filings/0001829126-26-008907.md) | [(2,764) d](/filings/0001829126-25-009077.md) | [(3,633) d](/filings/0001829126-26-002840.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | [7.1](/filings/0001829126-26-002840.md) | [4.6](/filings/0001829126-26-002840.md) | | Gross margin | % | not reported | not reported | not reported | [82.0%](/filings/0001829126-26-002840.md) | [87.4%](/filings/0001829126-26-002840.md) | | Operating margin | % | not reported | not reported | not reported | [(192.4%)](/filings/0001829126-26-002840.md) | [(383.5%)](/filings/0001829126-26-002840.md) | | Net margin | % | not reported | not reported | not reported | [(271.7%)](/filings/0001829126-26-002840.md) | [(294.0%)](/filings/0001829126-26-002840.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $m | not reported | not reported | not reported | [(7.4)](/filings/0001829126-26-002840.md) | [(10.4)](/filings/0001829126-26-002840.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cxai/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [WOLVERINE ASSET MANAGEMENT LLC](/funds/1279891.md) | 2026-06-30 | $57.8k | 1,014,438 | | Reduced −700 | | [TORONTO DOMINION BANK](/funds/947263.md) | 2026-06-30 | $52.2k | 949,005 | | Reduced −170 | | [Walleye Trading LLC](/funds/1388391.md) | 2026-06-30 | $29.4k | 515,198 | | Unchanged | | [Davidson Kempner Capital Management LP](/funds/1595082.md) | 2026-06-30 | $20.0k | 350,042 | | Unchanged | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $19.9k | 350,000 | Call | Unchanged | | [Oasis Management Co Ltd.](/funds/1317904.md) | 2026-06-30 | $18.6k | 100,000 | | Unchanged | | [TENOR CAPITAL MANAGEMENT Co., L.P.](/funds/1346554.md) | 2026-06-30 | $8.6k | 150,000 | | Unchanged | | [HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND](/funds/1535845.md) | 2026-06-30 | $7.1k | 125,000 | | Unchanged | | [LMR Partners LLP](/funds/1578621.md) | 2026-06-30 | $5.7k | 100,001 | | Unchanged | | [Greenland Capital Management LP](/funds/1896430.md) | 2026-06-30 | $5.2k | 99,192 | | Unchanged | ## Recent filings [All 280 filings](/companies/cxai/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 12:30 ET | [8-K](/filings/0001829126-26-011430.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-26-011430 | | 2026-09-03 | 12:05 ET | [8-K](/filings/0001829126-26-009692.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-009692 | | 2026-08-19 | 10:01 ET | [8-K/A](/filings/0001829126-26-009035.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001829126-26-009035 | | 2026-08-14 | 21:19 ET | [10-Q](/filings/0001829126-26-008907.md) | Quarterly report, period 2026-06-30 | 0001829126-26-008907 | | 2026-08-14 | 20:31 ET | [8-K](/filings/0001829126-26-008889.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001829126-26-008889 | | 2026-07-06 | 20:30 ET | [8-K](/filings/0001829126-26-007295.md) | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001829126-26-007295 | | 2026-06-23 | 20:05 ET | [8-K](/filings/0001829126-26-006763.md) | 5.07 Shareholder vote results | 0001829126-26-006763 | | 2026-06-03 | 20:35 ET | [8-K](/filings/0001829126-26-006014.md) | 3.02 Unregistered sale of equity | 0001829126-26-006014 | | 2026-06-03 | 20:30 ET | [8-K](/filings/0001829126-26-006013.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-006013 | | 2026-05-28 | 21:15 ET | [8-K](/filings/0001829126-26-005752.md) | 3.02 Unregistered sale of equity | 0001829126-26-005752 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001829126-26-002840.md), filed Mar 30, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/d49e4c9e-d694-4bef-b51b-125b40e6cdcb) ## About the filer - CIK: 1820875 - Tickers: CXAI, CXAIW - Exchange: Nasdaq - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.